Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Julie R. Jonsson"'
Autor:
V. Suppiah, Jacob Nattermann, Elizabeth E. Powell, Antonina Smedile, M. Michalk, Mandvi Bharadwaj, Sherie Smith, Shona Fletcher, Martin Weltman, Julie R. Jonsson, Elizabeth Snape, David Sheridan, Gregory J. Dore, Patrick McClure, Richard Norris, Helen Barrie, M.L. Abate, David R. Booth, Dianne How-Chow, Thomas Berg, Jacob George, Jason Grebely, G. J. Stewart, Stephen M. Riordan, Margaret Bassendine, Sacha Stelzer-Braid, Golo Ahlenstiel, William L. Irving, Ulrich Spengler, Tobias Mueller, Nicola J. Armstrong, Vincenzo Fragomeli, Barbara Malik, Kate S. O'Connor, Tanya L. Applegate, Gail V. Matthews
Publikováno v:
BASE-Bielefeld Academic Search Engine
IL28B polymorphisms strongly predict spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. A recent study proposed a 32-base pair deletion in the CC-chemokine receptor 5 (CCR5) gene (CCR5-D32) interacting with the IL28B po
Autor:
Andrew D. Clouston, Elizabeth E. Powell, Richard Skoien, C.-J. Bergqvist, Leigh U. Horsfall, Julie R. Jonsson
Publikováno v:
Internal Medicine Journal. 43:247-253
Background/Aim Subjects with metabolic risk factors for non-alcoholic fatty liver disease (NAFLD) are commonly seen by hospital specialists other than gastroenterologists/hepatologists. The aim of this study was to assess the awareness of NAFLD and o
Autor:
Elizabeth M. Brunt, Nicholas Manton, Martin Weltman, Andrew D. Clouston, Rachel M. Brown, Michelle M. Richardson, Herbert Tilg, Elizabeth E. Powell, Brent A. Neuschwander-Tetri, Julie R. Jonsson, Paul E. O'Brien, Prithi S. Bhathal, Richard Couper, Ulrich Baumann, Looi C. Ee, Richard Skoien, John Dixon, Alexander R. Moschen
Publikováno v:
Liver International. 33:624-632
Background Adult non-alcoholic fatty liver disease (NAFLD) involves lobular necroinflammatory activity and fibrosis is typically centrilobular, whereas paediatric NAFLD has predominantly portal fibrosis. The reasons for these differences are unclear.
Autor:
Julie R. Jonsson, Charles A. Dinarello, Andrew D. Clouston, O. Bauhofer, Ralf Bartenschlager, Alexander R. Moschen, Elizabeth E. Powell, Soohyun Kim, Teresa Fritz, Helen Barrie, Ilka Rebhan, Herbert Tilg
Publikováno v:
Hepatology, 53, 1819-29
Hepatology, 53, 6, pp. 1819-29
Hepatology, 53, 6, pp. 1819-29
Interleukin 32 (IL-32) is a recently described proinflammatory cytokine that activates p38 mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kappa B), thereby inducing proinflammatory cytokines such as IL-1 beta and tumor necrosi
Autor:
Andrew D. Clouston, Julie R. Jonsson, Soo Hyun Kim, Herbert Tilg, Elizabeth E. Powell, Alexander R. Moschen, Ralf Bartenschlager, Ilka Woerz, Charles A. Dinarello, Teresa Fritz
Publikováno v:
Hepatology. 50:302A-401A
Autor:
Peter O'Rourke, Julie R. Jonsson, Stuart McPherson, Helen Barrie, Andrew D. Clouston, Elizabeth E. Powell
Publikováno v:
Journal of Hepatology. 49:1046-1054
Background/Aims: Increased expression of sterol regulatory element binding protein (SREBP)-1c, a transcription factor regulating lipogenesis, has been reported in HCV core protein-transfected hepatocytes. Our aim was to investigate the role of SREBP-
Autor:
Susan Ash, Elizabeth E. Powell, Judith Bauer, Emma Osland, Gary Cowin, Graham J. Galloway, D. M. Purdie, Julie R. Jonsson, Andrew D. Clouston, Azmat Ali
Publikováno v:
Journal of Magnetic Resonance Imaging
Purpose: To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods: Quantification of liver fat was compared by liver biopsy, proton MRS, and MRI using in-phase
Autor:
D. M. Purdie, Julie R. Jonsson, Andrew D. Clouston, Herbert Tilg, Anthony J. Demetris, Michelle M. Richardson, Alexander R. Moschen, Brent A. Neuschwander-Tetri, Elizabeth E. Powell, Prithi S. Bhathal, John Dixon, Elizabeth M. Brunt, Martin Weltman
Publikováno v:
Gastroenterology. 133:80-90
Portal fibrosis and linkage is a key feature of progressive disease in nonalcoholic steatohepatitis (NASH), but not simple steatosis. It is underappreciated and poorly understood. Fatty liver has impaired regeneration that induces a secondary replica
Publikováno v:
Clinics in Liver Disease. 11:173-189
As obesity prevalence rises, there is evidence that fatty liver disease can act synergistically with other chronic liver diseases to aggravate parenchymal injury. This is characterized best in chronic hepatitis C, where steatosis is caused by viral a
Autor:
David R. Booth, Ulrich Spengler, Duncan McLeod, Rosanna Santaro, Jacob Nattermann, Elizabeth E. Powell, Mohammed Eslam, Wendy Cheng, Reynold Leung, Tanya L. Applegate, Mark W. Douglas, Manuel Romero-Gómez, Elisabetta Bugianesi, Javier Ampuero, Lindsay Mollison, Chiara Rosso, Olfat G. Shaker, Vincent Wai-Sun Wong, Thomas Berg, Henry L.K Chan, Vijayaprakash Suppiah, Christopher Liddle, Alessandra Mangia, Rose White, M. Michalk, Janett Fischer, Gail V. Matthews, Margaret Bassendine, William L. Irving, Julie R. Jonsson, David Sheridan, Nicola J. Armstrong, Stephen M. Riordan, Maria Lorena Abate, Vincenzo Fragomeli, Barbara Malik, Jacob George, Martin Weltman, Gregory J. Dore, Golo Ahlenstiel, Jason Grebely, Ahmed M. Hashem, Leon A. Adams, Lavinia Mezzabotta
Publikováno v:
Nature Communications
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
Tissue fibrosis is a core pathologic process that contributes to mortality in ~45% of the population and is likely to be influenced by the host genetic architecture. Here we demonstrate, using liver disease as a model, that a single-nucleotide polymo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256bd01f18383f5b44e291dfec07cc03
https://hdl.handle.net/11541.2/118206
https://hdl.handle.net/11541.2/118206